Yung-Jin Kim Selected Research

Yung-Jin Kim Research Topics

Disease

22	Neoplasms (Cancer) 02/2024 - 03/2003
5	Hypoxia (Hypoxemia) 02/2011 - 01/2005
3	Inflammation (Inflammations) 09/2023 - 11/2012
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 11/2015
2	Stomach Neoplasms (Stomach Cancer) 11/2011 - 08/2003
1	Liver Neoplasms (Liver Cancer) 05/2019
1	Colorectal Neoplasms (Colorectal Cancer) 06/2018
1	Lewis Lung Carcinoma 04/2011
1	Vascular Diseases (Vascular Disease) 07/2010
1	Colonic Neoplasms (Colon Cancer) 03/2010
1	Ulcer 06/2007
1	Brain Neoplasms (Brain Tumor) 06/2006
1	Glioblastoma (Glioblastoma Multiforme) 06/2006
1	Glioma (Gliomas) 01/2006
1	Ovarian Neoplasms (Ovarian Cancer) 01/2005

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2010 - 01/2005
3	Transcription Factors (Transcription Factor)IBA 04/2013 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 03/2010 - 01/2005
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 06/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2013 - 03/2010
2	Angiogenesis InhibitorsIBA 11/2012 - 10/2006
2	Oxygen (Dioxygen)IBA 03/2010 - 01/2005
2	KR 31831IBA 06/2008 - 10/2006
2	PiperazineIBA 06/2005 - 08/2004
2	Messenger RNA (mRNA)IBA 01/2005 - 08/2003
1	Vitamin D FDA LinkGeneric 02/2024
1	LipopolysaccharidesIBA 09/2023
1	hispidulinIBA 09/2023
1	hepatitis B virus X proteinIBA 05/2019
1	Protein Isoforms (Isoforms)IBA 05/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2019
1	Antineoplastic Agents (Antineoplastics)IBA 05/2019
1	CalciumIBA 06/2018
1	Ethidium (Ethidium Bromide)IBA 06/2018
1	Apoptosis Regulatory ProteinsIBA 06/2018
1	XylitolIBA 07/2013
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2012
1	Membrane LipidsIBA 12/2012
1	Betaine (C.B.B.)FDA Link 11/2012
1	Histone Deacetylase InhibitorsIBA 11/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011
1	Histones (Histone)IBA 11/2011
1	Decitabine FDA Link 11/2011
1	Butyric Acid (Butanoic Acid)IBA 11/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2011
1	matrigelIBA 04/2011
1	ethyl pyruvateIBA 04/2011
1	Pyruvic Acid (Pyruvate)IBA 02/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2011
1	Plasminogen Activator Inhibitor 1IBA 02/2011
1	coenzyme Q10 (CoQ10)IBA 01/2011
1	ThromboxanesIBA 07/2010
1	ProstaglandinsIBA 07/2010
1	Conditioned Culture MediaIBA 03/2010
1	AntioxidantsIBA 03/2010
1	MelatoninIBA 03/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2010
1	QuercetinIBA 06/2007
1	Endothelial Growth FactorsIBA 06/2007
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2006
1	Interferon-alpha (Interferon Alfa)IBA 06/2006
1	Temozolomide (Temodar)FDA LinkGeneric 01/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2006
1	Thalidomide (Thalomid)FDA Link 01/2006
1	deoxyuridine triphosphateIBA 01/2006
1	SJ-8026IBA 06/2005
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2005
1	ThioredoxinsIBA 04/2005
1	ElementsIBA 01/2005
1	thymosin beta(10)IBA 01/2005
1	4- (3,5- dimethylphenyl)piperazine- 1- carboxylic acid (2- methoxy- 5,6- dimethylpyridin- 3- yl)amideIBA 08/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2003
1	Mitogen-Activated Protein Kinase 3IBA 08/2003
1	MAP Kinase Kinase 1IBA 08/2003
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 08/2003
1	Tissue Inhibitor of Metalloproteinase-3IBA 03/2003
1	GelatinasesIBA 03/2003

Therapy/Procedure

6	Therapeutics 11/2015 - 01/2006
1	Drug Therapy (Chemotherapy) 01/2021